{{Rsnum
|rsid=10988449
|Chromosome=9
|position=129608081
|Orientation=plus
|GMAF=0.1685
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=NTMT1
|Gene_s=NTMT1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 75.2 | 23.9 | 0.9
| HCB | 88.3 | 10.9 | 0.7
| JPT | 92.0 | 8.0 | 0.0
| YRI | 34.0 | 51.0 | 15.0
| ASW | 56.1 | 33.3 | 10.5
| CHB | 88.3 | 10.9 | 0.7
| CHD | 92.7 | 7.3 | 0.0
| GIH | 92.1 | 5.9 | 2.0
| LWK | 30.3 | 55.0 | 14.7
| MEX | 79.3 | 17.2 | 3.4
| MKK | 50.6 | 40.4 | 9.0
| TSI | 77.5 | 20.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22041458
|Trait=None
|Title=Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.
|RiskAllele=T
|Pval=0.000003
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}